These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


523 related items for PubMed ID: 15378542

  • 1. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP.
    Am J Med Genet A; 2004 Oct 15; 130A(3):221-7. PubMed ID: 15378542
    [Abstract] [Full Text] [Related]

  • 2. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
    McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP.
    Am J Med Genet A; 2005 Mar 01; 133A(2):165-9. PubMed ID: 15633195
    [Abstract] [Full Text] [Related]

  • 3. BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening.
    McInerney-Leo A, Hadley D, Kase RG, Giambarresi TR, Struewing JP, Biesecker BB.
    Am J Med Genet A; 2006 Oct 15; 140(20):2198-206. PubMed ID: 16969872
    [Abstract] [Full Text] [Related]

  • 4. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H.
    JAMA; 1996 Jun 26; 275(24):1885-92. PubMed ID: 8648868
    [Abstract] [Full Text] [Related]

  • 5. Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing.
    McKinnon W, Naud S, Ashikaga T, Colletti R, Wood M.
    J Genet Couns; 2007 Aug 26; 16(4):433-56. PubMed ID: 17594133
    [Abstract] [Full Text] [Related]

  • 6. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M, Frydman M, Friedman I, Shiri-Sverdlov R, Papa MZ, Goldman B, Friedman E.
    Am J Med Genet; 2002 Aug 01; 111(2):147-51. PubMed ID: 12210341
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants.
    Tercyak KP, Peshkin BN, Streisand R, Lerman C.
    Psychooncology; 2001 Aug 01; 10(4):336-46. PubMed ID: 11462232
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD, Hutson SP, Loud JT, Peters JA, Giusti RM, Greene MH.
    Health Expect; 2008 Sep 01; 11(3):220-31. PubMed ID: 18816319
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.
    Halbert CH, Wenzel L, Lerman C, Peshkin BN, Narod S, Marcus A, Corio C, Demarco T, Bellamy S.
    Cancer Epidemiol Biomarkers Prev; 2004 May 01; 13(5):875-81. PubMed ID: 15159322
    [Abstract] [Full Text] [Related]

  • 18. Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process.
    Wang C, Gonzalez R, Milliron KJ, Strecher VJ, Merajver SD.
    Am J Med Genet A; 2005 Apr 01; 134A(1):66-73. PubMed ID: 15690408
    [Abstract] [Full Text] [Related]

  • 19. Factors associated with an individuals' decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved?
    Caruso A, Vigna C, Bigazzi V, Leone C, Maggi G, Martayan A, Sega FM, Cognetti F, Savarese A.
    Fam Cancer; 2011 Sep 01; 10(3):581-9. PubMed ID: 21604195
    [Abstract] [Full Text] [Related]

  • 20. Impact of Implementing B-RSTTM to Screen for Hereditary Breast and Ovarian Cancer on Risk Perception and Genetic Counseling Uptake Among Women in an Academic Safety Net Hospital.
    Wernke K, Bellcross C, Gabram S, Ali N, Stanislaw C.
    Clin Breast Cancer; 2019 Aug 01; 19(4):e547-e555. PubMed ID: 31005475
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.